Congrats euan ashley !!…well- deserved…fond memories of Stanford Medicine asking you about heart stuff 😉

New #JITC article: IFNγ mediates the resistance of tumor cells to distinct NK cell subsets bit.ly/3xNJop7

And honored to work with Chrystal Paulos on the Society for Immunotherapy of Cancer awards committee! …she is fantastic! 🤗🎉👍🏼

Well, I think pre-med certainly is different than M3-4…I certainly had more perspective after I had worked w interns as a med student than when I was pre-med…regardless- system needs to change for the better! 🙏🏼

First author status!! Thanks Michael Slade, MD & Dr. Ramzi Abboud for all the mentorship 😊 Pretransplant desensitization of donor-specific anti-HLA antibodies with plasmapheresis and immunoglobulin produces… pubmed.ncbi.nlm.nih.gov/38990135/

Honest question (poll?) …do people still use the term “pimping” with respect to rounds etc…and if so- what are the origins, and should we be using it- or not??!!…definitely one of those medical “terms” you learn on the job and then wonder about! 🤔🤔

Strong work Jeff Sharman - proud to call you a fellow Stanford Medicine oncology fellow! …you may no longer be in the lab, but you’re still doing great work! 💪🏼🎉

RIP Bob Newhart As a child I would listen to a cassette of his standup and did my best to memorize the Driving Instructor routine because I knew when I repeated it I could make my parents and their grown-up friends laugh Absolute master of the form youtu.be/XaUYQZR-y7I?si…

The best at understated comedy 🎉

In *additional* great Doximity news, the Mallinckrodt Institute of Radiology Nuclear Medicine Residency ranked #1! Congratulations to Maria Rosana Ponisio, PD, and Dr. Farrokh Dehdashti, Division Chief!

Congratulations to Marcel Arias on our review of gamma delta T cells in cancer: rdcu.be/dO2GN

Excited to go talk about #GU ASCO updates at Total Health | Oncology 📖🔬 Kansas City with my friend Ravi A Madan M.D. - still time to register for free - come join us! 🎉 nam10.safelinks.protection.outlook.com/?url=https%3A%…

Want to know more about the Washington University Hem-Onc Fellowship Program WashU Heme/Onc Fellowship ? Check out our video below: #MedEd youtube.com/watch?v=OgfQEB… WashUOncology WashU Hematology Test Account WUSM Department of Medicine Siteman Cancer Center Barnes-Jewish

Thank you @UroToday & DrSartor for the opportunity to discuss a commentary in Journal of Clinical Oncology w/Rick Lee 이재방 Edwin Posadas, MD Fatima Yaftali Karzai, M.D. Peter Choyke & #EvanYu Fred Hutchinson Cancer Center ⚠️There is danger & no🚫data supporting #PSMA #PET 🩻restaging in #mCRPC #ProstateCancer⚠️ 🔗 ascopubs.org/doi/10.1200/JC…

Love it!! 🎉🎉🎉

Positive results from Part 1 of our Phase 2 ELIMINATE trial evaluating genetically engineered bacteriophage therapy, LBP-EC01, to treat #UTIs were published in The Lancet Infectious Diseases. Additionally, dosing has begun in Part 2 portion of this study. globenewswire.com/news-release/2…

#ICYMI: Positive results from Part 1 of our Phase 2 ELIMINATE trial are published in The Lancet Infectious Diseases! LBP-EC01, our CRISPR-Cas3 engineered #bacteriophage, targets #UTIs caused by #AMR & #MDR E. coli. locus-bio.com/locus-bioscien…

The next phase is underway with dosing now started in the randomized, controlled, and blinded Part 2, backed by BARDA. With 150M people affected by UTIs annually, innovative treatments like LBP-EC01 are vital. Stay tuned for more updates! #PhageTherapy eliminateuti.com

Amazing approach to circumvent antibiotic resistance! 🎉💪🏼

Same!…we need a #hashtag 🤣…especially difficult when reviewing grants or papers😳